| Interpretable systems biomarkers predict response to immune-checkpoint inhibitors Ó Lapuente-Santana, M van Genderen, PAJ Hilbers, F Finotello, F Eduati Patterns 2 (8), 2021 | 83 | 2021 |
| Tumor location is associated with mood dysfunction in patients with diffuse glioma MNG van Genderen, V Belgers, JM Niers, L Douw, JG Röttgering, ... Nature Mental Health 2 (7), 853-864, 2024 | 4 | 2024 |
| Agent-based modeling of the prostate tumor microenvironment uncovers spatial tumor growth constraints and immunomodulatory properties MNG van Genderen, J Kneppers, A Zaalberg, EM Bekers, AM Bergman, ... npj Systems Biology and Applications 10 (1), 20, 2024 | 3 | 2024 |
| P08. 06. A Work resumption following lower-grade glioma surgery: a multicenter cohort study IO Kommers, MNG van Genderen, RS Eijgelaar, MG Witte, Y de Haan, ... Neuro-oncology 24 (Suppl 2), ii44, 2022 | 2 | 2022 |
| Exploring the onset and progression of prostate cancer through a multicellular agent-based model M Passier, MNG van Genderen, A Zaalberg, J Kneppers, EM Bekers, ... Cancer Research Communications 3 (8), 1473-1485, 2023 | 1 | 2023 |
| Impact of resection location on depressive symptoms following glioma surgery V Belgers, MNG van Genderen, MT de Schotten, M Cakmak, L Douw, ... Neuro-Oncology Advances, vdae222, 2024 | | 2024 |
| Research briefing V Belgers, MNG van Genderen Nature 2, 747-748, 2024 | | 2024 |
| OS08. 7. A Depressive symptoms in association with tumor locations at diagnosis in patients with diffuse glioma MNG van Genderen, V Belgers, L Douw, F Barkhof, M Klein, JM Niers, ... Neuro-Oncology 25 (Suppl 2), ii19, 2023 | | 2023 |
| P09. 09. A RESECTION CAVITY LOCATIONS ASSOCIATED WITH CHANGES IN DEPRESSIVE SYMPTOMS AFTER SURGERY IN PATIENTS WITH DIFFUSE GLIOMA V Belgers, MNG van Genderen, M Cakmak, L Douw, F Barkhof, M Klein, ... Neuro-oncology 25 (Suppl 2), ii60, 2023 | | 2023 |
